Biomarker May Flag Humira Responders in Hidradenitis Suppurativa

Watchdoq January 12, 2025
(MedPage Today) -- Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc analysis of the PIONEER I and II trials found.
At 12 weeks...

Read Full Article